The public's confidence in AstraZeneca and Oxford University's COVID-19 vaccine is down noticeably in Europe and especially in France, a new poll has found — just as a large U.S. trial shows it to be 79 percent effective.
YouGov found in a new poll that in France, Germany, Spain, and Italy, "people are more likely to see the vaccine as unsafe than safe" after the vaccine's use was briefly paused there. This was particularly notable in France, where 61 percent of those surveyed said they think the vaccine is unsafe, up from 43 percent last month. In fact, just 23 percent of respondents in France said they believe the vaccine is safe. YouGov notes that even in February, though, more people in France thought the vaccine was unsafe than thought it was safe.
Meanwhile, 55 percent of respondents in Germany said they think the AstraZeneca vaccine is unsafe, and that number was 52 percent in Spain and 43 percent in Italy.
Subscribe to The Week
Escape your echo chamber. Get the facts behind the news, plus analysis from multiple perspectives.
Sign up for The Week's Free Newsletters
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
Use of the AstraZeneca vaccine was briefly paused in Europe amid concerns over whether it could be linked to blood clots, but it has since resumed, as the European Medicines Agency confirmed the vaccine to be safe and effective and found no increased blood clot risk. British Prime Minister Boris Johnson subsequently received a dose of the AstraZeneca vaccine and encouraged the public to do so as well.
According to YouGov, "only in Britain can the blood clots story be considered to have little to no impact," as the majority there continued to say they believe the vaccine to be safe. But elsewhere, YouGov writes, the decision to pause the vaccine's use in Europe "hugely damaged public perceptions of the vaccine's safety," with lead data journalist Matt Smith saying it has "undoubtedly suffered damage to its reputation for safety on the continent."
YouGov's poll was conducted by speaking to a group of roughly 8,000 people in seven countries from March 12 through March 18, according to Reuters. Read more at YouGov.
-
RFK Jr. shuts down mRNA vaccine funding at agencySpeed Read The decision canceled or modified 22 projects, primarily for work on vaccines and therapeutics for respiratory viruses
-
Measles cases surge to 33-year highSpeed Read The infection was declared eliminated from the US in 2000 but has seen a resurgence amid vaccine hesitancy
-
Kennedy's vaccine panel signals skepticism, changeSpeed Read RFK Jr.'s new vaccine advisory board intends to make changes to the decades-old US immunization system
-
Kennedy ousts entire CDC vaccine advisory panelspeed read Health Secretary RFK Jr. is a longtime anti-vaccine activist who has criticized the panel of experts
-
RFK Jr. scraps Covid shots for pregnant women, kidsSpeed Read The Health Secretary announced a policy change without informing CDC officials
-
New FDA chiefs limit Covid-19 shots to elderly, sickspeed read The FDA set stricter approval standards for booster shots
-
US overdose deaths plunged 27% last yearspeed read Drug overdose still 'remains the leading cause of death for Americans aged 18-44,' said the CDC
-
Trump seeks to cut drug prices via executive orderspeed read The president's order tells pharmaceutical companies to lower prescription drug prices, but it will likely be thrown out by the courts
